Search results
Results from the WOW.Com Content Network
In January 2016, the company received an investment from the Bill & Melinda Gates Foundation's Strategic Innovation Fund to support the development of antimalarial medication based on semi-synthetic artemisinin. [8] In April 2019, the company raised $34-million in private placement of its common stock and warrants.
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, [3] headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology.
Revolution Bioengineering is a biotech company in Fort Collins, Colorado, United States that is working to create a plant that changes color throughout the day on its own using synthetic biology techniques to harness genes involved in the color and internal clock systems in petunias. [1]
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Tom Knight is an American synthetic biologist and computer engineer, who was formerly a senior research scientist at the MIT Computer Science and Artificial Intelligence Laboratory, a part of the MIT School of Engineering. [1] He now works at the synthetic biology company Ginkgo Bioworks, which he cofounded in 2008. [2]
For premium support please call: 800-290-4726 more ways to reach us
The company was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Herbert Boyer. [ 9 ] [ 10 ] Boyer is considered to be a pioneer in the field of recombinant DNA technology. In 1973, Boyer and his colleague Stanley Norman Cohen demonstrated that restriction enzymes could be used as "scissors" to cut DNA fragments of ...